Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXC3LB
|
||||
Drug Name |
N-{2-[4-(8-Chloro-5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidin-1-yl]-2-oxo-ethyl}-benzamide
|
||||
Synonyms |
CHEMBL318886
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H26ClN3O2
|
||||
Canonical SMILES |
Clc1ccc2C(=C3CCN(CC3)C(=O)CNC(=O)c4ccccc4)c5ncccc5CCc2c1
|
||||
InChI |
InChI=1S/C28H26ClN3O2/c29-23-10-11-24-22(17-23)9-8-20-7-4-14-30-27(20)26(24)19-12-15-32(16-13-19)25(33)18-31-28(34)21-5-2-1-3-6-21/h1-7,10-11,14,17H,8-9,12-13,15-16,18H2,(H,31,34)
|
||||
InChIKey |
ZDYAXBJXENTPDQ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.